• [1]  . Partial splenic embolization combined with endoscopic therapies and vasoconstrictive drugs reduces rebleeding in cirrhosis patients with acute variceal bleeding and hypersplenism: a multicenter randomized controlled trial.  《JOURNAL OF GASTROENTEROLOGY》,  2023. 
• [2]  陶子文. Risk of Severe COVID-19 Increased by Metabolic Dysfunction-associated Fatty Liver Disease A Meta-analysis.  JOURNAL OF CLINICAL GASTROENTEROLOGY,  55,  830, 2021. 
• [3]  . Transarterial Chemoembolization Combined With Endoscopic Therapy Is Beneficial for Unresectable Hepatocellular Carcinoma With Esophagogastric Varices.  FRONTIERS IN ONCOLOGY,  11,  2021. 
• [4]  曾云青. DNA Methylation: An Important Biomarker and Therapeutic Target for Gastric Cancer.  FRONTIERS IN GENETICS,  13,  2022. 
• [5]  王忍忍. Safety and feasibility of early oral nutrition after endoscopic treatment for patients with liver cirrhosis: A historical prospective and comparative effectiveness study.  JOURNAL OF PARENTERAL AND ENTERAL NUTRITION,  2022. 
• [6]  陶子文. Influence of Nonalcoholic Fatty Liver Disease on the Occurrence and Severity of Chronic Kidney Disease.  JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY,  10,  164, 2022. 
• [7]  林译垦. A novel radiomics-platelet nomogram for the prediction of gastroesophageal varices needing treatment in cirrhotic patients.  HEPATOLOGY INTERNATIONAL,  15,  995, 2021. 
• [8]  高占娟. Portal vein thrombosis associated with high 14-day and 6-week rebleeding in patients after oesophageal variceal band ligation: a retrospective, multicentre, nested case-control study.  HEPATOLOGY INTERNATIONAL,  2021. 
• [9]  李立娟. A Multi-Organ Fusion and LightGBM Based Radiomics Algorithm for High-Risk Esophageal Varices Prediction in Cirrhotic Patients.  IEEE Access,  9,  15041, 2021. 
• [10]  孙欣. Partial splenic embolization combined with endoscopic therapies and NSBB decreases the variceal rebleeding rate in cirrhosis patients with hypersplenism: a multicenter randomized controlled trial.  HEPATOLOGY INTERNATIONAL,  2021.